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Involvement of p59fyn T in Interleukin-5 
Receptor Signaling 
By Mark  W. Appleby,$ James D. Kerner,~ Sylvia Chien,$ 
Charles R .  Maliszewski,  II Subbarao BondadaL** 
and Roge r  M. Perlmutter*$S82 
From the "Howard Hughes Medical Institute and the Departments of *Immunology, 
SBiochemistry, and IIMedicine (Medical Genetics), University of Washington, Seattle, Washington 
98195; 82 of Immunology, Immunex Corporation, Seattle, Washington 98101; 
and the **Department of Microbiology and Immunology, University of Kentucky, Lexington, 
Kentucky 40536 
Summary 
Previous studies implicate the nonreceptor protein tyrosine kinase (PTK) p59f~ in the propaga- 
tion of signals from the B cell antigen receptor. To elucidate the functions of this kinase, we 
examined B cell responsiveness in mice engineered to lack the hematopoietic isoform of p59fv~. 
Remarkably, antigen receptor signaling was only modestly defective in fyn T"u" B cells. In con- 
trast, signaling from the interleukin (IL)-5 receptor, which ordinarily provides a comitogenic 
stimulus with antiimmunoglobulin, was completely blocked. Our results document the impor- 
tance of p59fv"r in IL-5 responses in B cells, and they support a general model for cytokine 
receptor signal transduction involving the simultaneous recruitment of at least three families of PTK. 
B cells interact with antigen through a multisubunit com- 
plex, the B cell antigen receptor. The receptor is com- 
posed of membrane-bound Ig noncovalently associated with 
one or more copies of an c~fl heterodimer derived from the 
products of the rob-1 (Igor) and b29 (Igfl) genes. Engage- 
ment of the B cell antigen receptor by antigen provokes a 
number of biochemical events. These culminate in the acti- 
vation of resting B cells, their entry into the cell cycle, and 
the internalization of antigen, which is subsequently processed 
for presentation to T cells. An early event in this cascade is 
the phosphorylation of a number of cellular proteins upon 
tyrosine, suggesting that the activation of tyrosine kinases 
may be an obligate step in signaling from the antigen receptor 
(1-4). Indeed, both B cell proliferation (5) and the internali- 
zation of antigen are inhibited by treatment with tyrosine 
kinase inhibitors (6-8). 
The kinases believed to mediate B cell activation include 
members of the src, syk, and tec families (reviewed in refer- 
ence 9). For example, p72,rk is able to associate with the an- 
tigen receptor complex and becomes tyrosine phosphorylated 
after anti-Ig antibody stimulation of B cells (4, 10, 11). 
p70 b'k, a representative of the tec family of protein tyrosine 
kinases (PTKs) 1, has also been implicated in B cell signaling 
as a consequence of the abnormal B cell responses observed 
1 Abbreviations used in this paper: BCR, B cell receptor; PTK, protein tyro- 
sine kinase; TPN-Ficoll, trinitrophenyhted aminoethyi carboxymethyl-con- 
jugated Ficoll; TNP-KLH, trinitrophenol-conjugated KLH. 
in lymphocytes from mice bearing a missense mutation in 
the btk gene (12, 13). This kinase also assists in regulating 
B cell development, as revealed by the acute block in B cell 
ontogeny witnessed in humans lacking functional p7& 'k pro- 
tein (14, 15). 
Several members of the src family of protein tyrosine ki- 
nases, particularly p53/56~r ~, p59fr", p56 ~, and p56 bl~ have 
been identified in B cell receptor complexes, and the kinase 
activity of each of these has been reported to increase after 
anti-Ig stimulation (16-19). Association of these kinases with 
the antigen receptor appears to involve the Igc~/Igfl compo- 
nents of the antigen receptor (20, 21) and is dependent on 
the activation status of the receptor complex. Thus, in the 
resting state, a low affinity association between the amino 
terminus of p59fr ~ and a sequence within Igor appears to 
predominate. After B cell receptor (BCR) engagement, phos- 
phorylation of tyrosine residues in the antigen receptor acti- 
vation motif facilitates an association with p59fr" via its SH2 
domain, and results in an increase in kinase activity (21- 
23). p59fr~ is also capable of physical interaction with phos- 
pholipase Cqr2 (24), itself a target for tyrosine phosphory- 
lation after receptor engagement, and therefore appears to 
play an important role in signaling pathways emanating from 
the BCR. 
In addition to responding to antigenic stimulation, B cells 
also mature in response to numerous cytokines. These in- 
clude IL-7, implicated in the early stages of B cell develop- 
ment (25), and IFN-% IL-4, and IbS, which together par- 
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ticipate in the regulation of isotype switching (26, 27). An 
evolving body of literature suggests that these molecules exert 
their effects in part through the activation of another family 
of protein tyrosine kinases, the JAK family (reviewed in refer- 
ences 28, 29). The src family protein tyrosine kinases may 
also be active in cytokine signaling pathways, as evidenced 
by the physical and functional association between p56 ~k and 
the B chain of the IL-2 receptor (30), and between p5~r" and 
the II.,7 receptor (31, 32). 
We have previously described the generation of mice that 
lack expression of one isoform offyn, that expressed within 
hematopoietic cells (fynT), by targeted disruption (33). These 
fyn Tnun animals develop normally and are indistinguishable 
at a gross level from wild-type siblings. However they ex- 
hibit an exquisitely specific defect: mature thymocytes from 
fyn Tn~u mice are acutely refractile to stimulation through the 
TCR (33). 
Here we report that signaling from the B cell antigen 
receptor proceeds in a near-normal manner in the absence of 
p59fy". However, the absence of p59fv' in the B cell lineage 
is not without consequence: fyn Tn~u mice show impaired B 
cell responses after immunization, and these fyn T~n B cells 
fail to respond to signaling through the IL-5 receptor. These 
observations support a general model for the concerted ac- 
tion of multiple tyrosine kinases in cytokine receptor signaling. 
Materials and Methods 
Generation of Experimental Animals and Flow Cytometric Anal- 
ys/s. fynTn~l mice were generated as previously described and were 
maintained by brother x sister matings. Homozygous wild-type 
animals derived from the intercross offyn T§ animals were also 
maintained and used as controls (33). Animals were analyzed be- 
tween 8 and 12 wk of age. Single cell suspensions of splenocytes 
were prepared as previously described (33). Peritoneal exudate cells 
were harvested by lavage using PBS containing 10 ~tg/ml heparin 
(Sigma Chemical Co., St. Louis, MO). Cells were stained for sur- 
face expression of B220, IgM, IgD, and Lyl using PE-conjugated 
anti-Ly5 (Caltag Laboratories, San Francisco, CA), FITC-labeled 
anti-IgM (Southern Biotechnology Associates, Birmingham, AL), 
biotinylated anti-IgD (Binding Site Inc., San Diego, CA), and bio- 
tinylated anti-Lyl (PharMingen, San Diego, CA). Biotinylated anti- 
IgD and biotinylated anti-Lyl were subsequently visualized using 
streptavidin-TKICOLOR | (Caltag Laboratories). Events were col- 
lected in list mode files on a FACScan | flow cytometer and ana- 
lyzed using Lysys II software (Becton Dickinson & Co., Mountain 
View, CA). 
Mitogenic Responses of fyn rnutl Splenocytes and Bone Marrow. 
Purified splenic B cells were prepared by complement lysis of 
CD4 § and CD8 + T cells with the CD4- and CD8-specific mAbs 
GK1.5, 3.155, and 2.43. 4 x 10 s splenic B cells were cultivated 
in 200 ~tl RPMI supplemented with 10% FCS, 2 mM glutamine, 
10 mM Hepes buffer, pH 7.0, and 0.1 mM 2-ME, and 100 U/ml 
penicillin and 100 ~tg/ml streptomycin. 
CeUs were stimulated with goat anti-mouse IgM (Fab~ (Or- 
ganon Teknika, Durham, NC) at 50 #g/ml, bacterial LPS at 25 
Izg/ml (Difco Laboratories, Detroit, MI), recombinant routine IL-5 
(R & D Systems, Inc., Minneapolis, MN) at the concentrations 
indicated in the text, dextran sulfate at 3/~g/ml (Sigma Chemical 
Co.) or CD40 ligand-trimer (Immunex Research and Development 
Corp., Seattle, WA), as described in the text. After 48 h, cells were 
incubated with 3[H]thymidine for 18-24 h and then harvested 
onto printed glass fiber filter mats using a Tomtec harvester. Incor- 
poration of 3[H]thymidine was measured using an HEB-Wallac 
1205 Betaplate liquid scintillation counter (Wallace Inc., Gaithers- 
burg, MD). 
Bone marrow was harvested from femurs of control andf?n mull 
mice by aspiration with sterile HBSS. Cells were cultured in Iscove's 
modification of Eagle's medium, supplemented with 10% FCS, 2 
mM glutamine, 100 U/ml penicillin, and 100 ~tg/ml streptomycin, 
and stimulated with recombinant murine Ib3 and recombinant 
GM-CSF (a generous gift from Immunex Research and Develop- 
ment Corp.). Proliferation was assessed by measuring the incorpo- 
ration of 3[H]thymidine as described above. 
Calcium Analysis. The determination of levels of intracellular 
free calcium by flow cytometric analysis was performed as described 
previously (34). Splenocytes were stained for surface expression of 
B220 using PE-conjugated Ly5 (Cakag Labs) and stimulated with 
goat anti-mouse IgM (Fab')2 (Organon Teknika) or sheep anti- 
mouse IgD (Binding Site Inc.) at the indicated doses. Data were 
analyzed using MTIME software as described previously (35). 
Responses of fyn r'u Mice to Immunization with Thymic-de~ndent 
and-independent Antigens. Mice were injected intraperitoneaUy with 
1 #g of trinitrophenol-conjugated KLH (TNP-KLH) or 1 ~tg of 
trinitrophenylated aminoethyl carboxymethyl-conjugated Ficoll 
(TNP-Ficoll). Mice were bled 7 d after immunization and serum 
was prepared for ELISA analysis. Serum polyclonal IgM and IgG3 
levels and anti-TNP isotype levels were determined by ELISA as 
previously described (36). 
Immunoprecipitation and In Vitro Kinase Assay. Whole cell ly- 
sates of splenic B cells prepared by complement lysis of T cells were 
prepared as previously described (34). Immunoprecipitation-kinase 
assays were performed as described in Cooke et al. (34) or Tsukada 
et al. (14). Extracts were resolved by 10% SDS-PAGE and trans- 
ferred to nitrocellulose for exposure to film (X-Omat AR; Eastman 
Kodak Co., Rochester, NY). 
Association between p59f~ and p77 b'k. B cell blasts were derived 
from splenic B cells by stimulation with LPS at 50 #g/ml in RPMI 
supplemented as described above. After stimulation with rib5 at 
the doses described in the text, cells were lysed in a buffer con- 
taining 50 mM Tris HC1, pH 7.5, and 150 mM NaC1 supplemented 
with either 1% Triton X-100, 1% Brij 96, or 1% 3-[(3-chola- 
midopropyl)-dimethylammonio]-l-propane-sulfonate (CHAPS). Ki- 
nase reactions were performed as described above. Immune com- 
plexes were then solubilized by boiling in 2% SDS, diluted 20-fold, 
and divided into two aliquots, p77 b'k was immunoprecipitated 
from one of these as previously described (14) and p59f~ immu- 
noprecipitated from the second aliquot as a control. Phosphory- 
lated substrates were resolved by PAGE. 
Results 
B Cell Development Proceeds Normally in the Absence of 
p59frn. B cell development from pre-B cell to mature B cell 
can be divided into a number of developmental steps, charac- 
terized by the ordered expression of cell surface markers and 
by the rearrangement status of Ig genes (for a review see ref- 
erence 37). Since IL-7 assists in regulating B cell development, 
the reported association between the Ib7 receptor and p59~ 
(31, 32) suggested that B cell development in fyn Tnult mice 
might be compromised. Using carefully prepared populations, 
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we found that p 5 9 ~  is the Fyn isoform expressed in B cells 
and noted that fyn T~n mice lack fyn protein in both B and 
T cell compartments (data not shown). Hence, these animals 
afforded us the opportunity to assess the relevance of this in- 
teraction. Flow cytometric analysis of splenocytes from normal 
animals stained with mAbs to surface IgM and IgD permits 
the resolution of three subpopulations of ceils (Fig. 1 A), 
including an immature population expressing high levels of 
IgM but low levels of IgD. All three populations are repre- 
sented at equivalent levels in flow cytometric profiles from 
control and fyn T~n animals. Spleens from fyn~ mice also 
exhibit normal cellularity (data not shown) and express ap- 
propriate numbers of B220-bearing cells (Fig. 1 B). Hence, 
no gross abnormalities in B lymphopoiesis result as a conse- 
quence of the absence of p59fr'. 
Development of the B1 B cell lineage in the absence of 
p59f~ 'r was also examined. B1 B calls, which represent the 
products of a distinct developmental lineage (38), are large 
granular cells that express high levels of surface IgM, low-to- 
moderate levels of IgD and B220 and, in most cases, CD5 
(38). Although B1 B cells constitute only a small proportion 
of total splenocytes, such B cells represent the predominant 
lymphoid population in the peritoneal compartment (38). 
The analysis of large granular lymphocytes present in the peri- 
toneal cavity of wild-type mice revealed the presence of two 
populations of IgMb~ig ht calls, corresponding to Bla (CD5 + 
IgM +) and Blb (CD5- IgM +) calls. Both populations were 
equally represented in wild-type mice and in mice carrying 
the fyn Tn~n mutation (Fig. 1 C). 
Signaling through the B Cell Antigen Receptor Proceeds Nor- 
mally infyn ~utt Animals. In the absence of p59fr,r, T lym- 
phocyte development proceeds normally (33, 39). However, 
thymocytes from fyn rnun mice exhibit a substantially com- 
promised response to stimulation through the TCR (33). We 
therefore evaluated B lymphocyte function infyn r~uu mice in 
an attempt to identify an analogous signaling defect within 
the B cell lineage. 
The effects of antigenic stimulation on B lymphocytes can 
be mimicked by treatment in vitro with antibodies to surface 
IgM or IgD. B cell antigen receptor cross-linking promotes 
a number of readily measured physiologic events, including 
the proliferative expansion of mature B cells. This approach 
was used to assess the integrity of antigen receptor-mediated 
signaling pathways in thefyn T~ B cells. Fig. 2 illustrates the 
proliferative responses of splenic B cells from 12 fyn Tn~n 
animals stimulated with goat anti-mouse IgM at 50/xg/ml, 
represented as a percentage of the response of control animals 
analyzed simultaneously. The proliferative response is some- 
what heterogeneous, reflecting biological variation in the 
animals used in these studies. However, fyn Tubal B cells were 
clearly capable of sustaining a robust response to stimulation 
through surface immunoglobulin. Titration of the stimula- 
tory dose from 50-6.25 #g/ml did not perturb this response 
(Fig. 2 and data not shown). Thus, p59Yr"T is not an ob- 
ligate component of the B cell receptor signaling complex. 
A consistent observation, but one that is difficult to resolve 
satisfactorily in light of the healthy response to surface Ig 
stimulation, is that unstimulated splenic B cells ffomfyn ~h~n 
mice generally exhibited a lower basal level of proliferation 
as compared to control cells (see below). 
Splenic B cells can also be induced to proliferate after stim- 
ulation with the nonspecific mitogen, LPS. The mechanism 
of LPS activation has not been fully deciphered; however, 
LPS stimulation does not appear to elicit the activation of 
src family tyrosine kinases (2, 3), leading to the suggestion 
that its mitogenic effect is independent of the B cell antigen 
receptor, fyn ah~n splenocytes retain the potential to respond 
to LPS and also to other B cell mitogens that bypass the an- 
tigen receptor, notably ionomycin and anti-CD72 antibodies 
(data not shown; references 40, 41). 
Early Biochemical Events after Antigen Stimulation. Although 
antigen receptor-induced mitogenesis appeared normal in the 
fyn Tnun background, there remained the potential for bio- 
chemical aberrations. Engagement of the antigen receptor pro- 
motes two early and immediate events: the phosphorylation 
of cellular proteins on tyrosine, as well as the rapid and tran- 
sient mobilization of intracellular calcium stores leading to 
elevation of intracellular free calcium levels. Both of these 
responses proceed in a normal manner in the absence of p59fyn 
(Fig. 3 and data not shown). In particular, the stimulation 
of splenocytes from wild-type andfyn Tnun animals with an- 
tibodies to surface IgM or IgD elicited a rapid dose-dependent 
mobilization ofintracellular calcium stores, with the responses 
in wild-type and fyn Tn~l animals virtually identical over a 
range of stimulatory doses (Fig. 3 and data not shown). Thus, 
by the criteria evaluated here, signal transduction from the 
B cell antigen receptor exhibits no obligate requirement for 
p59f'/nT. 
Antibody Responses in flmT'~n Animals. To evaluate the im- 
munological competence offyn T~I animals more thoroughly, 
their ability to respond to immunization with both thymic- 
dependent and -independent antigens was assessed. 
Levels of serum IgM, IgG1, and IgG3 present in nonim- 
munized fyn rnun mice were comparable to those present in 
age-matched control animals (data not shown), fyn a'n~u mice 
thus appeared capable of maintaining a normal antibody re- 
sponse to routinely encountered environmental agents. More- 
over, although there was some heterogeneity among the re- 
sponses of individual animals, fyn ~ n  mice proved capable of 
mounting a satisfactory antibody response to immunization 
with the thymic-dependent antigen TNP-KLH (Fig. 4 A). 
These normal thymic-dependent responses are consistent with 
our previous observation that peripheral T cell (as opposed 
to thymocyte) function is not severely compromised in 
fyn Tn~a mice (33). 
fyn Tn~n mice immunized with the thymic-independent an- 
tigen TNP-Ficoll mount an IgM response that is indistin- 
gnishable from that of control animals. TNP-Ficoll immuni- 
zation, however, elicits substantially less robust IgG3 responses 
in fyn T~ll mice compared with control animals (Fig. 4 B). 
An inability to respond to immunization with thymic- 
independent antigens has previously been described in the 
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Figure 1. Flow cytometric analysis of lymphocytes ~omfyn Tn~ll mice and control animals. (A and B). Splenocytes from 8-wk-old animals were stained 
for the expression of  the cell surface molecules IgM and IgD (A) or B220 (B) as described in Materials and Methods. 20,000 events were collected 
in list mode files on a FACScan | flow cytometer and analyzed using Lysys II software. The percentage of events contained in individual populations 
is indicated. (C) Peritoneal cells.were harvested as described in Materials and Methods, and were stained as described above. The plot shown was generated 
by gating on large granular lymphocytes present in the peritoneal cavity 
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CBA/N mouse strain, and is characteristic of mice bearing 
a mutation (XID) in the Btk PTK (12, 13, 42). Fig. 4 B illus- 
trates that the XID mutation has a far more profound effect 
upon the IgG3 response than that observed as a consequence 
of thefynT mutation, and in addition compromises the IgM 
response and reduces the levels of IgM and IgG3 in preim- 
mune serum (Fig. 4 B and references 42, 43). 
Impaired Cytokine Responses in fyn T=u Animals. The simi- 
larity of the B cell defect seen after immunization offyn T"~ 
animals with TNP-FicoU to that observed in XID mice 
prompted an examination of other B cell responses known 
to be compromised by the XID mutation. For example, XID 
B cells respond poorly to the costimulatory effects of Ib5 
(44). To assess the integrity of the IL-5 receptor signaling 
pathway, splenic B cells were cultured in vitro and stimu- 
lated with Ib5 plus CD40 ligand trimer, or IL-5 plus dex- 
tran sulfate, two mitogen combinations that support B cell 
growth and the generation of antibody-secreting cells. Prolifer- 
ative responses were assessed after 48 h in culture (45). 
Both dextran sulfate and CD40 ligand alone dicit very 
modest proliferative responses when supplied to B lympho- 
cytes (Fig. 5, A and B). As previously reported, costimula- 
tion with Ib5 delivers a potent, dose-dependent, comitogenic 
signal. However, no IL-5-induced enhancement of B call 
proliferation occurs infyn ~ splenocytes, which mount little 
response over that seen after treatment with dextran sulfate 
or CD40 ligand trimer alone (Fig. 5, A and B). 
The Ib5 receptor shares a common subunit (Be) with two 
other cytokine receptors, the GM-CSF receptor and, in 
humans, the IL-3 receptor (reviewed in reference 46). The 
signaling potential of all three receptors is believed to reside 
in part in this Bc chain, as shown by the detrimental conse- 
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Figure 4. Antibody responses in fyn TnunL mice. Control and fyn TnuH mice were immunized with the thymic-dependent antigen TNP-KLH or the 
type 2 thymic-independent antigen TNP-Fico]l, and sera were collected after 7 d. The figure illustrates the serum titers of TNP-Ficoll-specific lgM 
and IgG3 and TNP-KLH-specific IgM, IgG1, and IgG3. Each symbol represents the response of an individual control (circle), fyn *r~'aL (square), or CBA/N 
(~ triangle) animal. Horizontal bars represent mean responses. The mean IgG3 log3 control response (4.58) differs significantly from that offyn ~11 
mice (2.36; P <0.001 by Student's t test). 
quences of deletion of the 3c chain in factor-dependent cell 
lines expressing mutant receptors (47, 48). A defect in IL-5 
signaling in the fyn T"ull background suggested that fyn Tnun 
animals might exhibit analogous aberrations in GM-CSF sig- 
naling. To examine this hypothesis, the proliferative responses 
of bone marrow cells after stimulation with GM-CSF were 
assessed. Wild-type andfyn rnuu bone marrow cells exhibited 
similar proliferative responses over a range of stimulatory doses 
of GM-CSF and I1--3 (data not shown). We conclude that 
the absence of p59h" in B cells leads to a selective and es- 
sentially absolute defect in IL5 signaling. 
IL5-induced Activation of p77btk The observation that 
mutations inf)m and btk both compromise the response to 
Ib5, coupled with a previous report that these molecules as- 
sociate in the yeast two-hybrid system (50) prompted us to 
seek biochemical evidence for an interaction between p59fy" 
and p77 b~k in B cells. 
Since the in vitro kinase activity of p77 b~k has been 
reported to increase after stimulation of B cell lines with IL5 
(51), we asked whether this activation requires p59f~ expres- 
sion. Splenic B cells were prepared by complement lysis of 
T cells and stimulated to blast by culture in LPS, a process 
that augments surface expression of the Ib5 receptor (52). 
These B cell blasts were stimulated with recombinant mu- 
rine IL-5 and lysed as described. Immune complex kinase assays 
were performed, and autophosphorylation of p77 btk was 
quantitated using a phosphoimager. Fig. 6 A documents an 
IL-5-inducible increase in kinase activity in p77 b'k immune 
complexes from both control andfyn Tn~n animals. Hence, the 
activation of p77 stk by IL5 receptor ligation occurs indepen- 
dently of p59fr~. Such an observation suggests that if p77 btk 
and p59f~ contribute to a single pathway emanating from 
the IL-5 receptor, then their relationship must be such that 
p77 btk is the Ib5 receptor-proximal element. 
To document a physical association between p77 ~fk and 
p59fy", analogous to that reported in the yeast two-hybrid 
system (50), immune complexes of p59fy" were prepared 
from lysates of splenic B cells and a kinase reaction was per- 
formed as described above. The components of the Fyn 
immune complex were subsequently solubilized in SDS, 
subjected to a second round of immunoprecipitation using 
p59fr~- or p77btk-specific antibodies and then resolved by 
PAGE. Using this protocol, we were unable to detect phos- 
phorylated p77 bt~ among the components of p59f~ immune 
complexes prepared from lysates of splenic B cells solubilized 
with either Brij96 (Fig. 6 B, lane 4), Triton X-100, or CHAPS 
(data not shown). In control experiments, p59~ was readily 
reprecipitable in the SDS-solubilized immunecomplex (Fig. 
6 B, lane I ), suggesting that the failure to detect p77 btk was 
not a consequence of the solubilization regime. 
Although we were unable to detect the presence of phos- 
phorylated p77 bt~ in p59fr" immune complexes from resting 
splenic B cells, it seemed possible that such an interaction 
might take place given the appropriate physiological stimu- 
lation. Hence, Triton X-100, CHAPS, or Brij 96 lysates were 
prepared from splenic B cells stimulated with IL-5 and sub- 
jected to immune complex analysis. Once again, however, 
we were unable to detect p77 btk in these Fyn immune com- 
plexes (Fig. 6 B, lanes 5 and 6). 
Discuss ion 
Preliminary biochemical evidence has implicated p59fr~ in 
signal transduction from both the B cell receptor and the 
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Figure 5. Impaired cytokine responses infyn Tnul] mice. Splenic B cells 
were prepared from control or fynTnuH animals and stimulated with Ib5 
and dextran sulfate (A) or CD40 ligand trimer (B). Proliferation was as- 
sessed after 48 h by the incorporation of 3[H]thymidine and is presented 
as counts per minute. Assays were performed in triplicate; the experiment 
shown is representative of two (B) or five (.4) experiments. ~ ,  +/+; 
- + - ,  - / - ;  - . - - ,  - / - .  
T cell receptor: p59fr" associates with both TCRs  and 
BCKs, and p59fr~ activation is observed in both populations 
of cells after receptor engagement. However, the consequences 
of  the targeted inactivation of p59fr,r differ radically in these 
two populations. CD4 +8- or C D 4 - 8  + thymocytes that 
lack pS9fyn are acutely refractile to T C R  stimulation. In con- 
trast, splenic B cells carrying an identical mutation mount  
a response to receptor stimulation that is difficult to distin- 
guish from that of  normal animals. Hence, p59fr" is not an 
obligate participant in the B C R  signal transduction pathway. 
Whether  other kinases routinely subserve this function or 
simply act to replace p59& infyn Tnull B cells cannot be ascer- 
tained unambiguously. Indeed, identification of the major 
kinases responsible for B C K  signal transduction may require 
817 Appleby et al. 
Figure 6. (A) Induction of p77 ~k kinase activity by II~-5 B cell blasts 
cultured in Ib5 for 48 h were stimulated with rIL-5 at 100 ng/ml for the 
indicated periods of time, lysed, and p77 ~ immunoprecipitated. The prod- 
ucts of an in vitro kinase reaction were resolved by PAGE and the incorpo- 
ration of 32P("/)ATP was evaluated by phosphoimager analysis. II,  +/+; 
[~, - / - .  (B) p77 al is not detectable in p59f- immune complexes. B cell 
blasts from control animals were stimulated with rlL-5 at 140 ng/ml and 
lysed in 1% Brij 96. p59~ immune complexes were subjected to an in 
vitro kinase reaction and subsequently solubilized in SDS before reim- 
munoprecipitation with Fyn- or Btk-specific antiserum. Phosphorylated 
substrates were resolved by PAGE. Lanes 1 and 4, unstimulated; lanes 2 
and 5, stimulation with IL-5 for 1 min; lanes 3 and 6, stimulation with 
Ib5 for 5 min. 
the targeted inactivation of  the genes encoding all potential 
participants. Notwithstanding the seemingly normal responses 
of fyn Tnull B cells to anti-IgM stimulation, these cells mani- 
fest a readily demonstrable defect in IL-5 responses in vitro, 
and in antigen responses in vivo. 
The Ib5  receptor consists at min imum of c~ and 3 chains, 
the latter of  which is shared with the receptors for GM-CSF 
and (in humans) IL-3 (46). Involvement of  the Btk kinase 
in IIr signaling seems certain: Btk activity increases after 
IL-5 stimulation, and B cells from X I D  mice fail to respond 
to II.-5 costimulation. Our studies demonstrate that p59~ 
also participates in this signal transduction process. The acti- 
vation of Btk that occurs after II.-5 stimulation suggests that 
the failure to mount a mitogenic response to IL-5 is not a 
consequence of an intrinsic defect in the Ib5 receptor. Rather, 
the linkage of Btk activation to subsequent proliferative events 
appears to require p59Yr'. 
Although bone marrow cell proliferative responses to GM- 
CSF (and II.-3) remain normal in fyn Tnun mice, we cannot 
conclude that p59~ does not interact with the Bc chain. 
levels of p59fr" are exceedingly low in normal bone marrow 
cells (data not shown), and those cells that proliferate in re- 
sponse to GM-CSF may not actually express this protein. 
Hence, the normal response to GM-CSF and II--3 does not 
imply that p59fr~ in B ceils interacts with the unique ot chain 
of the Ib5 receptor. Direct identification of a physical associ- 
ation of p59fr" with the IL-5 receptor, if such exists, will re- 
quire biochemical studies in cells engineered to express high 
levels of the receptor; IIr receptor levels are barely detect- 
able on normal responding ceils. 
What, then, can be said of II.-5 receptor signaling in light 
of our results? First, two distinct PTKs, p77 ~ and p59fr", 
are both required for satisfactory costimulation of anti-IgM-in- 
duced proliferation by II~5 in normal B cells. Since a physical 
interaction between these two very different kinases has been 
detected using a yeast two-hybrid system (50), p59Yr" and 
p77 ~'k may regulate one another. However, the interaction 
between these two kinases, assessed either through coim- 
munoprecipitation or by an alteration in kinase activity, could 
not be demonstrated in normal B cells. Hence, we can only 
say that these two kinases act in concert. Obviously, if Ib5 
receptor stimulation in fact initiates a true kinase cascade, 
p77 btk must regulate p59~ in the signaling pathway, and not 
vice-versa. Furthermore, since fyn a'~ll mice manifest only 
some of the immune aberrations seen in xid mice, Btk must 
act on targets other than p59fr'. Together these observations 
suggest that Fyn and Btk both interact with the IL-5 receptor, 
but contribute to related parallel pathways. 
Precedent exists for the simultaneous involvement of mul- 
tiple nonreceptor PTKs in cytokine receptor signaling. In the 
IL-2 receptor, for example, interaction of the 7c receptor 
subunit with the Jak3 kinase, and of the B receptor subunit 
with Jakl, Lck, and Syk (through different mechanisms in 
each case), provides for engagement of seemingly indepen- 
dent signaling pathways involving the transcription factors 
Myc and Fos/Jun (30, 53-59), and of the Bcl-2 survival factor 
(60). Thus, four different PTKs act together to induce changes 
in the proliferative and differentiative character of responder 
cells. 
Our results and those of other groups suggest that the 
Ib5 receptor will couple in an analogous fashion to multiple 
parallel kinase pathways. The Jak2 kinase is activated as a con- 
sequence of II.-3, I1.-5, and GM-CSF receptor engagement, 
and it subsequently becomes associated with the membrane 
proximal region of/3c, a region previously reported to be re- 
quired for activation of c-myc, pira-1, and the execution of 
the mitogenic response (28, 61). A second domain within 
Bc is required for the activation of cytoplasmic tyrosine ki- 
nases and of the MAP kinase signaling cascade (47, 48, 62). 
In addition, a common motif has been defined in the unique 
c~ chains of the GM-CSF, I1.-3, and Ib5 receptors, which is 
required for signal transduction in factor-dependent cell lines. 
Phosphorylation of Jak2 after GM-CSF stimulation also re- 
quires an activity associated with the unique c~ chain (62, 
63). Hence, three distinct nonreceptor PTKs, Jak2, Btk, and 
Fyn, almost certainly act to convey the II.-5 signal. As a corol- 
lary, we suspect that the low basal proliferation characteris- 
tics offyn Tnun B cells (Fig. 2) results from an inability to re- 
spond to the cytokine mixture present in normal culture media. 
Thus, other as yet undefined cytokine receptor signaling 
pathways may act via p59fr~. 
Our studies demonstrate that p59r expression is required 
for satisfactory IL-5-induced signaling in mouse B lympho- 
cytes. A similar defect in humans could underlie rare cases 
of B cell immunodeficiency. 
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